Veratis Advisors’s Elevance Health ELV Stock Holding History

Veratis Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$389K	Buy	+1,000	New	+$399K	0.29%	55

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Veratis Advisors's ELV Position: Q3 2026 in Review

Veratis Advisors opened a new position in Elevance Health (ELV) in Q3 2026: 1,000 shares worth $389K. The stake represents 0.29% of the portfolio and ranks #55 among its holdings.

1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Veratis Advisors held 1,000 shares of Elevance Health worth $389K as of Q3 2026.
Elevance Health was a new Veratis Advisors position in Q3 2026.
Elevance Health made up 0.29% of Veratis Advisors's portfolio in Q3 2026, its #55 holding.
1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Veratis Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.